Methylation profiles of hMLH1 and RASSF1 genes and proteomic analysis in bladder cancer cell lines submitted to treatments with the antineoplastic drugs cisplatin and gemcitabine

• Grant number: 08/09147-6
• Support Opportunities: Regular Research Grants
• Start date: February 01, 2009
• End date: January 31, 2012
• Field of knowledge: Biological Sciences - Genetics - Mutagenesis
• Principal Investigator: Daisy Maria Favero Salvadori
• Grantee: Daisy Maria Favero Salvadori
• Host Institution: Faculdade de Medicina (FMB). Universidade Estadual Paulista (UNESP). Campus de Botucatu. Botucatu , SP, Brazil

Scientific publications

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

DA SILVA, GLENDA NICIOLI; FILONI, LEANDRO TOSHIO; SALVADORI, MARIA CECILIA; FAVERO SALVADORI, DAISY MARIA. Gemcitabine/Cisplatin Treatment Induces Concomitant SERTAD1, CDKN2B and GADD45A Modulation and Cellular Changes in Bladder Cancer Cells Regardless of the Site of TP53 Mutation. Pathology & Oncology Research, v. 24, n. 2, p. 407-417, APR 2018. (08/09147-6)

DE OLIVEIRA, DAIANE TEIXEIRA; VENTURA SAVIO, ANDRE LUIZ; DE CASTRO MARCONDES, JOAO PAULO; BARROS, TATIANE MARTINS; BARBOSA, LUDMILA CORREIA; FAVERO SALVADORI, DAISY MARIA; DA SILVA, GLENDA NICIOLI. Cytotoxic and toxicogenomic effects of silibinin in bladder cancer cells with different TP53 status. JOURNAL OF BIOSCIENCES, v. 42, n. 1, p. 91-101, MAR 2017. (08/09147-6)